Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
Clinical trial NCT02313909 · TERMINATED
Trial details
- NCT number
- NCT02313909
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-23
- Primary completion
- 2018-02-15
- Enrollment
- 7213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.